IMPELLA CP 0048-0003

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-01-11 for IMPELLA CP 0048-0003 manufactured by Abiomed Europe, Gmbh (germany).

Event Text Entries

[35611616] The impella cp was not returned for evaluation, so no device analysis could be performed. It is unclear at this time if the artery bleeding was as a result of any issue with the introducer, impella cp pump, guide-wire or if the issue occurred as a result of the patient's anatomy, device placement or the procedure that was performed. The manufacturer will continue to investigate all reasonable obtainable sources of information and will provide results and conclusions in a supplemental medwatch report if additional information is received. Device discarded by user.
Patient Sequence No: 1, Text Type: N, H10


[35611617] The complainant reported that a (b)(6) male patient presented with a segment elevation myocardial infarction (stemi:) resulting in an extracorporeal membrane oxygenation (ecmo) being placed in the patient. The patient also had three vessel disease (3vd) and his left ventricle was distended. The physician placed an intra-aortic balloon pump (iabp), as the patient's groin arteries were very small. The iabp did not decompress, resulting in an impella cp being placed in the patient. An antegrade sheath was also placed to provide flow down the patient's leg from the ecmo circuit. The impella cp was placed without issue in the patient. Following patient treatment, bleeding was observed to be emanating from the impella insertion site. The pump angle was adjusted, but the bleeding continued, so a femstop was applied. During patient transport a significant amount of blood was lost. The patient blood loss was reported to be in excess of 15m/l of blood per minute. A vascular repair was performed that was reported to have resolved the bleeding at the impella site. The patient was also reported to have significant bleeding from the ecmo site, and was unrelated to the bleeding from the impella pump. The patient was reported to have been administered 50 units of replacement blood, but it was reported that the replacement blood was "mostly due to the groin bleeding from the ecmo site. " the patient was reported to have been successfully supported for over 8 days with the impella cp, and was reported to be in stable condition at the conclusion of the impella cp support.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1220648-2016-00001
MDR Report Key5358815
Date Received2016-01-11
Date of Report2015-12-13
Date of Event2015-12-13
Date Facility Aware2015-12-13
Report Date2015-12-13
Date Reported to Mfgr2015-12-13
Device Manufacturer Date2015-11-15
Date Added to Maude2016-01-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. WILLIAM BOLT
Manufacturer Street22 CHERRY HILL DRIVE
Manufacturer CityDANVERS MA 01923
Manufacturer CountryUS
Manufacturer Postal01923
Manufacturer Phone9786461451
Manufacturer G1ABIOMED EUROPE, GMBH (GERMANY)
Manufacturer StreetNEUEHOFER WEG 3
Manufacturer CityAACHEN, GERMANY 13059, GM
Manufacturer CountryGM
Manufacturer Postal Code13059, GM
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameIMPELLA CP
Generic NameIMPELLA CP, PRODUCT CODE: PBL
Product CodePBL
Date Received2016-01-11
Model NumberIMPELLA CP
Catalog Number0048-0003
Lot Number1213544
Device Expiration Date2017-08-01
OperatorPHYSICIAN
Device AvailabilityN
Device Age2 MO
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABIOMED EUROPE, GMBH (GERMANY)
Manufacturer AddressNEUEHOFER WEG 3 AACHEN, GERMANY 13059, GM GM 13059, GM


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-01-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.